🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Anna Ferguson

Johns Hopkins University

ORCID: 0000-0003-2739-8445

Also affiliated with Johns Hopkins Medicine

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A randomized, phase II trial of adjuvant immunotherapy with durable TKI-free survival in patients with chronic phase CML”.

A randomized, phase II trial of adjuvant immunotherapy with durable TKI-free survival in patients with chronic phase CML

Leukemia Research(2021)10.1016/j.leukres.2021.106737

N/A

0.330DataRank · unranked

8 citations

Tara M. Robinson, Amanda L. Blackford, Erica D. Warlick, Anna Ferguson, Ivan Borrello +4 more

A phase I study of a mutant KRAS-targeted long peptide vaccine combined with ipilimumab/nivolumab in resected pancreatic cancer and MMR-proficient metastatic colorectal cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps814

N/A

0DataRank · unranked

16 citations

Thatcher Heumann, Maureen Berg, Anna Ferguson, Su Jin Lim, Hao Wang +6 more

A phase I study of a mutant KRAS-targeted long peptide vaccine in patients at high risk of developing pancreatic cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps758

N/A

0DataRank · unranked

11 citations

Carol Judkins, Anna Ferguson, Elizabeth Abou Diwan, Su Jin Lim, Hao Wang +7 more